JD

Jostein Dahle

Co-founder and Chief Technology Officer

BlueHaven Therapeutics

Therapeutic Areas

BlueHaven Therapeutics Pipeline

DrugIndicationPhase
Lead Program (unspecified)Glioblastoma (GBM)Preclinical